Aims. To review the epidemiology, dissemination, clinical presentation, diagnosis, treatment, survival and functional outcome of intramedullary spinal cord metastases (ISCM).
INTRODUCTION
Intramedullary spinal cord metastases (ISCM) are infrenquent and clinically affect only 0.1-0.4% of all cancer patients [1] [2] [3] . Most present with rapid progressive neurological deficits and require immediate examination 1,2,4-6 . Currently, spinal magnetic resonance imaging (MRI) is applied routinely for diagnosis 3, [7] [8] [9] [10] [11] . Surgery aims at decompression of functional neural tissue and histological confirmation of tumor 6 . As with other central nervous system (CNS) metastases, patients with ISCM have a very short life expectancy, with a median survival of 3 to 4 months from the time of diagnosis 3, 4, 12 . I review here all surgically treated patients series in the literature.
DISCUSSION AND REVIEW OF THE LITERATURE

Epidemiology
Of all spinal tumor locations, extradural (ED) is the most common (55%), being located primarily in the vertebral bodies and the epidural fat. Regardless of their histology, ISCM are even more rare accounting for only 0.9-5% of all spinal metastases 1, 2, 13, 14 . This is particularly striking, since intracerebral metastases account for 55% of all intracranial tumors 6 . ISCM constitutes only 8,5% of all central nervous system (CNS) metastases [1] [2] [3] 15, 16 . Buchholz 17 first described metastases in the spinal cord parenchyma in 1897. Lung cancer (54%) with breast carcinoma (11%) accounted for a majority of ISCM cases 16 . Physicians diagnose only 5% of these metastases before death 18 however, with advanced imaging techniques like MRI, there has been recorded a progressive increase in its frequency 3, 8, 9, 19 . ISCM is found together with leptomeningeal disease (LMD) in 15-55% of the cases 3, 9, 20 .
Dissemination
Three different routes for the spread of tumors to the spinal cord have been hypothesized. Haematogeneous spread is belived to account for most cases [1] [2] [3] [4] [5] 9, 18, [21] [22] [23] . The common coexistence of pulmonary metastasis and brain metastasis supports the idea of dissemination through the arterial route 4, 13 . Another haematogeneous route is spread through the vertebral venous plexus (Batsonś venous plexus), extending from the pelvis to the cranial venous sinuses, and enabling retrograde transportation to the spinal cord 1, 2, 13 . The second mechanism is related to leptomeningeal dissemination by the cerebrospinal fluid. Tumor cells originating from carcinomatous meningitis may infiltrate the Virchow-Robin spaces of vessels, penetrating the spinal cord and pial membrane and invading the spinal cord parenchyma 1, 2, 13, 18 . The third mechanism is direct invasion from contiguous structures. Although the dura protects the cord from invasion by malignant neoplasms 13 , eventual direct extension of a metastatic tumor from the spinal extradural space or CSF or nerve roots, through the dura and into the cord, and spread along perineural space to subarachnoid space and to cord parenchyma have been suggested 17, 18 .
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Clinical presentation
In patients with ISCM, weakness was present at time of presentation in 93%, sensory loss in 78% and urinogenital dysfunction in 62% of patients 3, 7, 8, 9, 13, 16, 24 . Brown-Sequard syndrome, defined as unilateral weakness or spasticity with contralateral loss of pain and temperature sensation was found in 23% (ref. 3, 16 ). Radicular pain was seen as a presenting symptom in 24 to 33% of patients 1, 2, 4, 16, 25 . Rapid progression of the symptoms distinguishes ISCM from primary intramedullary tumors, which appear to typically present with a slower progression 7, 9 . The other major differential diagnosis in the group of patients is far more common epidural spinal cord compression due to the extradural spinal metastasis 9, 18, 26, 27 . ISCM patients are mostly old and neurological findings associated with myelopathy presents more acutely 5, 27, 28 . At the time of the diagnosis most ISCM patients have systemic metastases and nearly half of all ISCM cases have brain metastases 3 . For these reasons, the brain and spinal cord need to be screened by MRI.
Diagnosis
With the widespread use of MRI, ISCM is being encountered with increasing frequency as it was often underdiagnosed or unconfirmed before the advent of MRI 9 . Gadolinium MRI has a high sensitivity in identifying such lesions. Furthermore, T2-weighted imaging demonstrates the edema related to metastasis with great success 3, 10, 11, 16, 19, 20, 29 . MRI with gadolinium has proven high sensitivity in the detection of intramedullary and spinal leptomeningeal neoplasms 29, 30 . Other diagnostic tests such as plain radiographs of the spine, myelography, post-myelography computerized tomography (CT) scan, and lumbar puncture with cerebrospinal fluid (CSF) examinations have much less value in the diagnosis of ISCM 3, 26 . Although the CSF is frequently abnormal, with an elevated protein value, it infrequently contains malignant cells 5, 18, 23 . Grem et al. 4 found malignant cells in 4 of the 22 ISCM cases (18%) in their series. If there is a spinal LMD concomitant with ISCM, the percentage of malignant cells present in CSF is between 50% and 75% (ref. 3, 30 ). Several authors have demonstrated that PET/CT particularly with fluorine-18-fluorodeoxyglucose (F 18 -FDG) enables examination of the entire spinal cord and thus permits the detection of ISCM, especially those of renal or lung origin [31] [32] [33] [34] .
Treatment
Three treatment modalities are available for ISCM: radiotherapy, chemotherapy, and surgery. The gold standard remains radiotherapy, with or without steroids to reduce edema 1, 2, 4, 23, 35, 36 . There are some reports of long-lasting remission after irradiation, but these are limited to patients in whom a very early diagnosis was made and/or who had highly radiosensitive tumors such as small-cell carcinoma or lymphoma 4, 23, [35] [36] [37] [38] . Treatment with steroids offered no additional survival benefit when combined with radiation therapy 4 .
Studies on the efficacy of chemotherapy are limited but failed to show any survival advantage 36 . Holoye et al. 36 have described tumor ablation (lung small-cell carcinoma of the lung) with cyclophosphamide, methotrexate, and lomustine, but neurological deficits and survival remained unchanged. Weissman and Grossmann recommended treatment with both intrathecal chemotherapy and radiotherapy in patients with ISCM or meningeal small-cell carcinomatosis 39 . Surgery has become an alternative option in an increasing number of cases because of the increased speed and accuracy of diagnostic imaging and advances in microsurgical techniques 5, 17, 27 . Surgical resection can be performed in selected cases only and several factors are important when considering surgery 5, 10, 11, 16, 22, 27, 38, 40 . Patient age and performance status affect the candidacy for surgical treatment. The location and severity of the primary neoplasm, as well as other metastases, weigh heavily in evaluating the prognosis, as well as anesthesia and surgical risks. Biological characteristics of the tumor itself should also be considered. Tumors that are known to be highly radioresistant should be preferentially indicated for surgical intervention. Technically, ISCM without leptomeningeal involvement is ideally suited for surgery. ISCM can be removed safely in many cases, since most ISCM are well encapsulated and some are cystic. Cystic tumors often lend themselves to surgical extirpation because the cystic component often reaches the surface of the cord and can therefore be more easily removed without disruption to normal structures 17 . In case of leptomeningeal involvement, radical excision is impossible. The preferred option is to limit removal to the well-defined portion of the tumor 34 . Dam-Hieu et al. 34 reported one case of succesful surgical treatment of leptomeningeal infiltration of medullary conus and cauda equina and this review reports a second case. This case suggests the possibility of neurological improvement after surgical release of agglutinated (by leptomeningeal infiltration) nerve roots of cauda equina.
Based on surgical findings, the surgeon has to find a balance between radicality and risk for functional deterioration. Complete surgical removal of ISCM should be reserved for those cases where a clear plane of cleavage allows unproblematic microsurgical dissection of the lesion 6 . Histology also infleunces surgical radicality. All poorly differentiated carcinomas and all sarcomas are difficult to dissect due to the lack of a clear plain of cleavage 6 . It is only within the last few years, since the development of MRI, that surgical treatment of ISCM has become a realistic treatment option. Up to January 2009 we were able to find an additional 42 references of 87 surgically treated cases of ISCM through a biomedical database search - Developments in imaging now allow reliable diagnosis, and advances in surgical microscopy have brought these tumors into the domain of neurosurgical care. Early suspicion of ISCM and treatment before the development of paralysis is required to improve neurologic deficit and survival of patients diagnosed with ISCM 12 . Radical resection of an ISCM is indicated in all patients who presents with rapid progressive neurological deficits 16 .
Survival and functional outcome
Kalayci et al. 16 reported, that improvement was seen in 66%, no change in 25%, and deterioration in 9% of all cases ISCM after treatment. In patients treated with a conservative regiment, 50% improved, 28% showed no change, and 22% deteriorated. In patients with surgical resection improvement was seen in 77%, and no change was seen in 23% of cases. Deterioration was not reported in his group 16 . The survey is nearly twice longer in surgical resection group compared to conservatively treated patients 16 . Histological type and grade of the tumor represented a major determinant of patient survival. Patients with intramedullary poorly differentiated carcinomas survived shortest, patients with adenocarcinomas longest 68, 69, 70 . Patients with lung cancer showed worse prognosis than those with breast cancer, with median survival 1.0 month vs. 5.5 months 12 . Interestingly, survival time was independent of CSF findings. Thus, carcinomatous meningitis is not always negative predictive factor for survival 6 . Despite of recent improvements, ISCM has an poor prognosis. After the appearance of the first symptom, mortality rate in 3-4 months is 80% of cases 4, 10, 16, 47, 71 .
CONCLUSIONS
Three treatment modalities are available for ISCM: radiotherapy, chemotherapy, and surgery. The gold standard remains radiotherapy.
Microsurgical resection of a focal intramedullary mass appears to be feasible and should be considered in selected cases. Patients who have no evidence of widespread organ metastases or multiple intramedullary lesions and who have a life expectancy of at least a few months with tumours of non-lymphoma histology should be considered for tumor resection.
In conclusion, ISCM are difficult to treat lesions, but early diagnosis, careful surgical management and maintenance therapy may substantially contribute to a satisfactory functional outcome and prolonged survival.
